Pulmonary Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Your baby was born before 32 weeks of pregnancy (premature birth)
- A parent or guardian has signed the consent forms to take part in the study and to allow personal data to be used
- Your baby has been diagnosed with a lung condition called bronchopulmonary dysplasia (BPD), which is a chronic lung disease that can develop in premature babies
- Your baby is currently receiving oxygen through low-flow nasal cannulas (small tubes that sit just inside the nostrils and deliver a gentle flow of oxygen)
Who may not be able to join:
- A parent or guardian has not signed the required consent forms for participation or for personal data use
- Your baby has been diagnosed with other serious long-term conditions beyond BPD that could cause low oxygen levels, such as significant heart defects present at birth, developmental disorders of the brain or nervous system, genetic conditions linked to breathing problems, central apneas (pauses in breathing controlled by the brain), or severe obstructive sleep apnea
- Your baby has another long-term lung or breathing condition in addition to BPD, such as cystic fibrosis or ongoing problems caused by repeatedly inhaling fluids (chronic aspiration)
- Your baby's current long-term home oxygen therapy is not working well enough to manage their condition (confirm with trial site)
- Your baby has a tracheostomy (a surgical opening in the throat used for breathing)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Richard Plavka, prof., General Hospital University in Prague
Phone: +420725441408
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Average duration of controlled oxygen therapy in a premature infant
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.